News
- Author:
- Ted Bosworth
Publish date: June 19, 2021
A much larger role for telemedicine in clinical care appears inevitable after the COVID-19 pandemic experience.
News
- Author:
- Ted Bosworth
Publish date: June 17, 2021
Several antipsychotics that show efficacy against negative symptoms are in advanced stages of development, said Dr. Henry A. Nasrallah.
News
- Author:
- Ted Bosworth
Publish date: June 16, 2021
Western and proinflammatory diets are associated with increased risk of gout independent of other factors.
News
- Author:
- Ted Bosworth
Publish date: June 15, 2021
Phase 3 trial shows secukinumab is effective for enthesitis-related arthritis and juvenile psoriatic arthritis in children.
News
- Author:
- Ted Bosworth
Publish date: June 11, 2021
Reimbursement for CPAP requires adherence, but there is a Catch-22.
News
- Author:
- Ted Bosworth
Publish date: June 10, 2021
The infrastructure bill might be an uncommon opportunity to alter health care policies in current political climate.
News
- Author:
- Ted Bosworth
Publish date: June 8, 2021
Increased air pollution parallels increased RA flares in a novel study undertaken in an industrial city.
News
- Author:
- Ted Bosworth
Publish date: June 5, 2021
The MUC5B promoter variant is associated with a large increased risk of interstitial lung disease in patients with rheumatoid arthritis.
News
- Author:
- Ted Bosworth
Publish date: June 4, 2021
Nintedanib slowed progression of interstitial lung disease associated with rheumatoid arthritis in a subgroup analysis of a phase 3 trial.
News
- Author:
- Ted Bosworth
Publish date: June 3, 2021
Intravenous immunoglobulin was safe and effective for dermatomyositis in the first multinational, phase 3, placebo-controlled trial to evaluate the...
News
- Author:
- Ted Bosworth
Publish date: May 25, 2021
For major outcomes, cooling comatose cardiac arrest patients to 31° had no advantage over 34° in a controlled trial.
News
- Author:
- Ted Bosworth
Publish date: May 24, 2021
In GALACTIC-HF trial, the greatest relative benefit of omecamtiv mecarbil was in the sickest HFrEF patients.
News
- Author:
- Ted Bosworth
Publish date: May 20, 2021
An FDA warning for paclitaxel-coated endovascular devices appears unwarranted, according to new data.
News
- Author:
- Ted Bosworth
Publish date: May 18, 2021
The SGLT2 inhibitor dapagliflozin was not associated with significant benefit in COVID-19 patients but came close.
News
- Author:
- Ted Bosworth
Publish date: May 16, 2021
In STEMI patients, event rates following complete revascularization guided by fractional flow reserve or angiography were similar.
